Cite
HARVARD Citation
Wei, L. et al. (2021). Targeting the miR-6734-3p/ZEB2 axis hampers development of non-small cell lung cancer (NSCLC) and increases susceptibility of cancer cells to cisplatin treatment. Bioengineered. 12 (1), pp. 2499-2510. [Online].